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P U B L I S H E D B Y E L S E V I E R I N C .CORRECTION
Curtis AB, Beck H.The Subcutaneous Implantable Cardioverter-Deﬁbrillator:
When Less Is More
J Am Coll Cardiol 2015;65:1616–8.
In the following sentence, the incorrect value of 4% was given where 0.4% was meant. The correct sentence is
as follows. This correction has been made online.
Fortunately, by using the inclusion and/or exclusion criteria in these 2 studies, the future need for system
revision to allow transvenous pacing was quite low (0.4%).
The authors apologize for the error.http://dx.doi.org/10.1016/j.jacc.2015.04.028CORRECTION
Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR,
Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenﬁeld K,
Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H,
Krucoff MW.Evaluation and Treatment of Patients With Lower Extremity
Peripheral Artery Disease: Consensus Deﬁnitions From
Peripheral Academic Research Consortium (PARC)
J Am Coll Cardiol 2015;65:931–41.
In Table 3 of this paper reference 34 was inadvertently omitted. The corrected table is printed below and has
also been corrected online.TABLE 3 PARC Lesion and Vessel Characteristics and Deﬁnitions
Lesion or Vessel Term Deﬁnition
Signiﬁcant peripheral artery stenosis* Mild <50%
Moderate 50%–69%
Severe 70%–99%
Occluded 100%
Lesion length Focal #1 cm
Short >1 and <5 cm
Intermediate $5 and <15 cm
Long $15 cm
Degree of lesion calciﬁcation (34,26) Focal <180 (1 side of vessel) and less than one-half of the total lesion length
Mild <180 and greater than one-half of the total lesion length
Moderate $180 (both sides of vessel at same location) and less than one-half
of the total lesion length
Severe >180 (both sides of the vessel at the same location) and greater than
one-half of the total lesion length
Continued on the next page
TABLE 3 Continued
Lesion or Vessel Term Deﬁnition
Anatomic level of LE-PAD Aortoiliac Aortoiliac (distal limit bottom of pelvic rim in the AP view by angiography
or inguinal ligament)
Femoropopliteal Femoropopliteal (distal limit is origin of anterior tibial artery)
Tibialpedal Tibialpedal (anterior tibial and below including foot arteries)
Aortoiliac segment Infrarenal abdominal aorta
Common iliac artery
Internal iliac artery
External iliac artery
Femoropopliteal Common femoral artery
Profunda femoris artery
Superﬁcial femoral artery
P1 segment (above knee popliteal artery): from Hunter’s canal to proximal
edge of patella
P2 segment: from the proximal part of patella to center of knee joint space
P3 segment (below knee popliteal artery): from the center of knee joint space
to origin of anterior tibial artery
Tibialpedal Tibial-peroneal trunk (from the origin of the anterior tibial artery to the
bifurcation of the posterior tibial and peroneal artery)
Anterior tibial artery
Posterior tibial artery
Peroneal artery
Plantar pedal loop
pedal vessel
PT, DP†‡
Target lesion Any vascular segment treated or attempted to be treated during the trial procedure with the index
device. The target lesion is the treated segment including 10 mm proximal and ending 10 mm distal
to the index device or therapy (stent, balloon, or atherectomy catheter).
TLR TLR is any repeat intervention of the target lesions (plus 10 mm proximal and distal to the index device)
or surgical bypass of the target vessel performed for restenosis or other complication involving the
target lesion. If the target vessel is occluded and bypass is done to another artery below the knee,
this should be considered TLR. In the assessment of TLR, angiograms should be assessed by an
angiographic core laboratory (if designated) and made available to the clinical endpoints committee
for review.
Target vessel Any vessel (e.g., noncardiac or nonintracranial) that contains the target lesion treated with the study
device. The target vessel includes the target lesion as well as the entire length of native vessel
upstream and downstream from the target lesion, including side branches.
Target limb Any symptomatic limb that contains the target lesion and all vessels from aortic bifurcation to the foot.
The majority of the anatomic classiﬁcations were adapted from Diehm et al. (7). *Lesion stenoses are clinically based on visual angiographic assessments. For clinical trials,
lesion stenosis may be evaluated with core-laboratory QCA. †PARC recommends continued efforts to encourage documentation of pedal anatomy in relevant patients. ‡It is
desirable to obtain selective tibial imaging evaluating the vascular supply to tissue at risk with categorization of pedal/arcuate vessels in patients with tissue loss.
DP ¼ dorsalis pedis artery; PT ¼ posterior tibial artery; QCA ¼ quantitative coronary angiography; TLR ¼ target lesion revascularization; other abbreviations as in Table 2.
J A C C V O L . 6 5 , N O . 2 3 , 2 0 1 5 Corrections
J U N E 1 6 , 2 0 1 5 : 2 5 7 8 – 9
2579The authors apologize for this error.http://dx.doi.org/10.1016/j.jacc.2015.04.049NOTICE
Retraction notice to “Can Grayscale IVUS Detect Necrotic Core-Rich Plaque?” [J Am Coll Cardiol 2014;64:2435-6]
Erling Falk, MD
From the University of Copenhagen, Copenhagen, Denmark
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/
locate/withdrawalpolicy).
This article has been retracted at the request of the Editor-in-Chief. We cannot conﬁrm the identity of
this author after an inquiry from a reader. We contacted the author directly but did not receive a response.
http://dx.doi.org/10.1016/j.jacchttp://dx.doi.org/10.1016/j.jacc.2015.05.003
